Both Semaglutide and Mounjaro represent innovative strategies to treating type 2 diabetes, and increasingly, obesity. Tirzepatide is a dual agonist that impacts two receptors involved in metabolism: GLP-1 and another https://things-to-know-about-tir342236.scrappingwiki.com/2707672/comprehending_tirzepatide_and_mounjaro_the_detailed_explanation